Niclosamide reverses SARS-CoV-2 control of lipophagy
T. Garrett, H. Coatsworth, I. Mahmud, T. Hamerly, C. J. Stephenson, H. Yazd, J. B. Ayers, M. Miller, J. A. Lednicky, R. R. Dinglasan
This study shows niclosamide reduces SARS-CoV-2 replication by modulating lipophagy and lipid metabolism in infected cells.
bioRxiv · Jul 11, 2021 · PreprintMicrobiology